LGND insider trading — Ligand Pharmaceuticals Inc
Over the last 90 days, insiders at Ligand Pharmaceuticals Inc (LGND) made 0 open-market purchases worth $0 and 2 open-market sales worth $2.43M, making them net sellers by $2.43M. The largest sale was by Haas Jason (Director), who sold 7,138 shares for $2.09M on Aug 12, 2026.
Updated Oct 16, 2026.
Recent LGND insider transactions
Every Form 4 filed by Ligand Pharmaceuticals Inc officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2026 | Reardon Andrew | CLO & Secretary | M · Option exercise · 10b5-1 | Direct | 340 | $52.27 | $18K | Form 4 |
| Oct 2, 2026 | Reardon Andrew | CLO & Secretary | S · Sale · 10b5-1 | Direct | 5,000 | $304.07 | $1.52M | Form 4 |
| Sep 22, 2026 | Zimmermann Martine | Director | F · Tax withholding | Direct | 115 | $298.50 | $34K | Form 4 |
| Sep 10, 2026 | Zimmermann Martine | Director | S · Sale | Direct | 1,200 | $285.00 | $342K | Form 4 |
| Sep 3, 2026 | Reardon Andrew | CLO & Secretary | S · Sale · 10b5-1 | Direct | 5,000 | $286.09 | $1.43M | Form 4 |
| Aug 12, 2026 | Espinoza Octavio | Chief Financial Officer | M · Option exercise · 10b5-1 | Direct | 31,641 | $56.91 | $1.80M | Form 4 |
| Aug 12, 2026 | Espinoza Octavio | Chief Financial Officer | S · Sale · 10b5-1 | Direct | 31,641 | $292.06 | $9.24M | Form 4 |
| Aug 12, 2026 | Haas Jason | Director | M · Option exercise | Direct | 6,138 | $51.56 | $316K | Form 4 |
| Aug 12, 2026 | Haas Jason | Director | S · Sale | Direct | 7,138 | $292.81 | $2.09M | Form 4 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | M · Option exercise · 10b5-1 | Direct | 5,000 | $52.27 | $261K | Form 4 |
| Aug 3, 2026 | Reardon Andrew | CLO & Secretary | S · Sale · 10b5-1 | Direct | 5,000 | $288.99 | $1.44M | Form 4 |
LGND insider trading FAQ
Are insiders buying LGND stock?
Not on the open market. In the last 90 days, Ligand Pharmaceuticals Inc insiders made no open-market purchases, and 2 open-market sales totaling $2.43M. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading LGND?
Recent sellers: Haas Jason, Zimmermann Martine.
Where does LGND insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.